Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|18|9|868-876

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.18, Iss.9, 2017-12, pp. : 868-876

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current Understanding of HSP90 as a Novel Therapeutic Target: An Emerging Approach for the Treatment of Cancer

By  

Current Pharmaceutical Design, Vol. 22, Iss. 20, 2016-06 ,pp. : 2947-2959

Bentham Science Publishers

Access to resources Recommend Favorite

The Therapeutic Target Hsp90 and Cancer Hallmarks

By  

Current Pharmaceutical Design, Vol. 19, Iss. 3, 2013-01 ,pp. : 347-365

Bentham Science Publishers

Access to resources Recommend Favorite

Hsp90: A Novel Target for Cancer Therapy

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 11, 2006-06 ,pp. : 1205-1214

Bentham Science Publishers

Access to resources Recommend Favorite

Multiclass Comparative Virtual Screening to Identify Novel Hsp90 Inhibitors: A Therapeutic Breast Cancer Drug Target

By  

Current Topics in Medicinal Chemistry, Vol. 15, Iss. 1, 2015-01 ,pp. : 57-64

Bentham Science Publishers

Access to resources Recommend Favorite

Tau protein as a therapeutic target in Alzheimer’s disease and other neurodegenerative disorders

By Larner A.J.  

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 10, 1999-10 ,pp. : 1359-1370

Informa Healthcare

Access to resources Recommend Favorite